1. Home
  2. |Insights
  3. |WEBINAR: Antitrust in Transition – What to Expect in the First 100 Days — C&M's First 100 Days Series

WEBINAR: Antitrust in Transition – What to Expect in the First 100 Days — C&M's First 100 Days Series

Webinar | 02.02.17, 8:00 AM EST - 9:00 AM EST

Register

Federal antitrust enforcement ramped up significantly during Obama’s second term, pushing the envelope of the FTC’s authority under Section 5, challenging mergers at a steady clip and alleging broad theories of harm in conduct cases brought under Section One of the Sherman Act. Will the Trump administration change course? If so, should we expect an immediate impact? How much will personnel decisions affect the course of events?

Key topics:

  • Taking stock: where are we now? What happens before new officials at the DOJ and FTC are nominated and confirmed?
  • Is now a good time to do your deal? What will successful deal advocacy look like in the short and longer term?
  • Will the new leadership take the more laissez-faire approach historically associated with Republican administrations, or will the new era bring something new entirely?
  • How will international and state regulators respond to a new federal approach?
  • How can companies take practical steps to manage risk in this uncertain environment?

Partners Joe Miller, Jeane Thomas, and Ryan Tisch will be speaking in this webinar.

For more information, please visit these areas: Litigation and Trial

Participants

Insights

Webinar | 10.16.25

The Artificial Intelligence Agenda from Capitol Hill to State Capitals: Where We Are and Where We Are (Probably) Going

The landscape of AI governance and regulation is shifting. Following the release of the White House’s “America’s AI Action Plan” in July 2025 and the President’s signing of related Executive Orders, the White House has emphasized (at least rhetorically) a preference for innovation, adoption, and deregulation. But that does not tell the entire story. The Administration remains committed to exercising a heavy hand in AI, including by banning the U.S. government’s procurement of so-called “woke AI,” intervening in the development of data centers and the export of the AI technology stack, imposing an export fee for certain semiconductors to China, and assuming a stake in a U.S. semiconductor company. State legislatures are also racing to implement their own regulations, particularly around AI’s use in critical areas, such as healthcare, labor and employment, and data privacy. The many sources of regulation raise the specter of a fragmented compliance environment for businesses. This webinar will delve into the Administration’s AI strategy, going beyond the headlines to analyze:...

View All Insights